Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
NCT00903240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2011-06-08
Summary
The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine
Conditions
- Bladder Cancer Recurrence
Sponsors & Collaborators
-
Predictive Biosciences
lead INDUSTRY
Principal Investigators
-
Ellen Sheets, MD · Predictive Biosciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-10-31
Countries
- United States
Study Locations
More Related Trials
-
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
NCT00776178 ·Status: COMPLETED
-
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
NCT00233402 ·Status: COMPLETED ·Phase: PHASE3
-
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
NCT03673202 ·Status: UNKNOWN
-
Bladder Cancer Patient-Reported Outcomes
NCT01090388 ·Status: COMPLETED
-
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
NCT06020807 ·Status: COMPLETED
-
To Detect the Sensitivity of the UroMark Assay
NCT02781428 ·Status: COMPLETED
-
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112 ·Status: COMPLETED ·Phase: NA
-
The Cxbladder Monitoring Study
NCT02700659 ·Status: COMPLETED
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
Bladder Cancer Screening Trial
NCT05646485 ·Status: RECRUITING ·Phase: NA
-
Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
NCT06870253 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
NCT02560584 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
NCT06878027 ·Status: RECRUITING
-
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
NCT03125460 ·Status: COMPLETED
-
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
NCT00872495 ·Status: RECRUITING
-
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
NCT02400944 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
NCT06235853 ·Status: COMPLETED
-
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
NCT06331299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
NCT06986304 ·Status: RECRUITING
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
Biomarker Discovery and Application in Bladder Cancer
NCT00962052 ·Status: UNKNOWN
-
UroX Biomarker Bladder Cancer Study
NCT03973307 ·Status: UNKNOWN
-
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982 ·Status: RECRUITING
-
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
NCT06991868 ·Status: RECRUITING